Bharat Biotech inks pact with Alopexx for anti-microbial vaccine

Bharat Biotech has partnered with Alopexx, Inc. to co-develop and commercialize the anti-microbial vaccine AV0328 in India and other low-income countries. The collaboration aims to address antimicrobial resistance through vaccination, with Alopexx receiving upfront and milestone payments, as well as royalties on future sales in licensed territories.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/tMWp0zS
via IFTTT